Compare YCBD & OXBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | YCBD | OXBR |
|---|---|---|
| Founded | 2015 | 2013 |
| Country | United States | Cayman Islands |
| Employees | 42 | 4 |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.6M | 7.9M |
| IPO Year | N/A | N/A |
| Metric | YCBD | OXBR |
|---|---|---|
| Price | $0.73 | $1.03 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $2.00 | ★ $5.00 |
| AVG Volume (30 Days) | ★ 1.3M | 23.9K |
| Earning Date | 05-15-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $12.70 | $80.09 |
| Revenue Next Year | $7.00 | $85.22 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.48 | $0.66 |
| 52 Week High | $2.56 | $2.85 |
| Indicator | YCBD | OXBR |
|---|---|---|
| Relative Strength Index (RSI) | 42.55 | 59.42 |
| Support Level | $0.63 | $0.99 |
| Resistance Level | $0.80 | $1.05 |
| Average True Range (ATR) | 0.06 | 0.07 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 17.81 | 91.89 |
cbdMD Inc is a United States based company. It owns and operates the consumer hemp-based cannabidiol (CBD) brand, cbdMD, Paw CBD as well as ATRx Labs brand of functional mushrooms. The company's product categories include CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD oils, and CBD pet products. The firm distributes its products through an e-commerce website, wholesalers, and a variety of brick-and-mortar retailers.
Oxbridge Re Holdings Ltd is a specialty property and casualty reinsurer that provides reinsurance solutions through its subsidiary. The company focuses on underwriting fully collateralized reinsurance contracts for property and casualty insurance companies in the Gulf Coast region of the United States, with an emphasis on Florida. It specializes in underwriting medium-frequency, high-severity risks where insufficient data exists to effectively analyze the risk/return profile of reinsurance contracts. The company generates revenue from three principal sources: premiums assumed from reinsurance on property and casualty business; income from investments, including unrealized gains or losses on other investments; and income from SurancePlus management fees.